LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo.
about
Klotho gene polymorphisms are related to colorectal cancer susceptibility.Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF-β-mediated epithelial-mesenchymal transition via the ERK/AKT signaling pathway.
P2860
LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@en
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@nl
type
label
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@en
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@nl
prefLabel
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@en
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
LYTAK1, a novel TAK1 inhibitor ...... l growth in vitro and in vivo.
@en
P2093
Bing Zheng
Jiansong Ji
Jinchang Wu
Jundong Zhou
Shuyu Zhang
P2860
P2888
P304
P356
10.1007/S13277-014-2961-2
P577
2014-12-19T00:00:00Z